Oracle has introduced new enhancements to its Oracle Argus and One shot Solutions to support pharmacovigilance teams in improving efficiency and complying with global regulations. These enhancements aim to streamline processes, enhance data privacy, and optimize reporting for clinical trials and post-marketing surveillance. By automating workflows and leveraging AI and machine learning technologies, Oracle’s solutions help pharmaceutical and medical device companies meet country-specific regulatory requirements and reporting obligations.
The new capabilities in Oracle’s pharmacovigilance portfolio include features such as smart duplicate search, improved end-of-study disclosure, updates to personally identifiable information reporting in Europe, eMDR regulation compliance for medical device reporting, and CIOMS-I report updates. These enhancements are designed to increase operational productivity, ensure compliance with data privacy regulations, and improve reporting accuracy and completeness.
In addition, Oracle’s Security One shot is an AI-powered solution that automates the ingestion of security source documents into Argus, saving time and streamlining case intake procedures. New Security One shot capabilities include automated email reception for individual case safety reports and CRO support for serving multiple companies or clients. These features help improve workflow efficiency and data segregation, enabling organizations to better meet the needs of their customers.
The new features are now available for Oracle’s Argus and Security One shot Solutions. For more information, visit https://oracle.com/argus and https://oracle.com/security-one-ingest. Oracle Life Sciences is a trusted leader in cloud technology, pharmaceutical research, and consulting, supporting professionals in clinical research and pharmacovigilance activities worldwide. With over 20 years of experience, Oracle Life Sciences is committed to leveraging real-world evidence to accelerate innovation and improve patient outcomes.
Oracle is a leading provider of integrated applications and secure infrastructure on the Oracle Cloud. For more information about Oracle and its offerings, visit www.oracle.com. Oracle, Java, MySQL, and NetSuite are registered trademarks of Oracle Corporation. Oracle’s commitment to innovation and supporting the life sciences industry in delivering breakthroughs and improving patient outcomes is evident in its continuous efforts to enhance its pharmacovigilance solutions.
Article Source
https://www.prnewswire.com/news-releases/oracle-advances-safety-case-management-for-life-science-organizations-302192427.html